Alcon terminated its PowerVision intraocular lens (IOL) technology program after recent clinical study data showed unpredictable postoperative outcomes. The program’s termination resulted in a $402 ...

Alcon is officially ending its PowerVision IOL technology program after disappointing clinical study data. As a result, the Geneva, Switzerland-based company is taking a $402 million write-off related ...

Alcon discontinued the intraocular lens programs it acquired through its 2019 purchase of PowerVision after clinical study data showed persistent unpredictable post-surgical visual outcomes in a ...

Sean had WaveLight Plus LASIK at OVO LASIK + Lens, the first clinic in the U.S. selected to offer the technology. The system uses light tracing and more than 1,500 data points to create a personalized ...

The non-exclusive license agreement pairs Alcon's PCIOL optical designs with RxSight's post-operative light-adjustable platform, with the aim of allowing surgeons to fine-tune visual outcomes after ...

Alcon and RxSight have announced a $200 million collaboration to develop post-operative adjustable presbyopic correction intraocular lenses (PCIOLs), marking a strategic pivot for Alcon after years of ...

Please provide your email address to receive an email when new articles are posted on . The lens will combine light-adjustable technology from RxSight with optical designs from Alcon. RxSight will ...

Alcon and RxSight are pairing up to jointly develop a new adjustable lens to give surgeons the ability to fine-tune visual outcomes for cataract patients following surgery. The eyecare specialists are ...

Alcon (NYSE:ALC) and RxSight (Nasdaq:RXST) announced that they entered into a non-exclusive intraocular lens (IOL) collaboration. The companies intend to jointly develop adjustable ...

Alcon and RxSight have entered a non-exclusive collaboration to develop adjustable presbyopia-correcting IOLs by combining Alcon's IOL designs with RxSight's light-adjustable technology The companies ...

The AcrySof IQ Vivity extends depth of focus so cataract patients see more clearly at multiple distances with fewer halos than classic multifocal lenses. This bestseller stays in focus for holders of ...